¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Transitory neonatal endocrine disorder, unspecified"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
¿µ¹® narcissistic personality disorder ÇÑ±Û ÀÚ±â¾ÖÀû ÀΰÝÀå¾Ö
¼³¸í   
  ÀÚ½ÅÀÇ Á߿伺°ú µ¶Æ¯ÇÔ, À¯ÀÏÇÔ¿¡ ´ëÇÑ ±¤ÀûÀΠÁýÂø°ú ÀÚ½ÅÀÌ ¼º°øÇÒ °ÍÀ̶ó´Â Áö³ªÄ£ ÁýÂøÀ» º¸¿©Áִ ¼º°ÝÀå¾Ö. Áö³ªÄ£ Àڱ⿡ÀÇ ¸¸Á·°¨À» °¡Áö°í, Áö³ªÄ£ Àڽۨ, ¼º°ø¿¡ ´ëÇÑ È®½ÅÀ» Áö´Ï°í ÀÖ´Ù.
¿µ¹® conversion disorder ÇÑ±Û ÀüȯÀå¾Ö
¼³¸í   
  ³»ºÎÀÇ °¥µî¿¡ ´ëÇÑ ¹«ÀǽÄÀû ¹æ¾î¸ÞÄ¿´ÏÁòÀ¸·Î ³»ºÎÀÇ °¥µîÀ» Æ¯Á¤ÇÑ ½ÅüÀÇ Áõ»óÀ¸·Î º¯È¯ÇÏ¿© ³ªÅ¸³»´Â °ÍÀ» ¸» ÇÑ´Ù. ÀÌ ÀüȯÀ¸·Î ÀÎÇÑ Áõ»óÀ» ÁַΠ³ªÅ¸³»´Â Á¤½ÅÁúȯÀ» ÀüȯÀå¾Ö¶ó°í ÇÑ´Ù. ÀüȯÀ¸·Î ÀÎÇÑ Áõ»óÀ¸·Î ´ëÇ¥ÀûÀΠ°ÍÀ¸·Î´Â ¸¶ºñ, °æ·Ã, ÀǽÄÀå¾Ö µîÀÌ´Ù. ´ë°³ ±× º´À» ÀÏÀ¸Å³ ¸¸ÇÑ º´º¯ÀÌ Á¸ÀçÇÏÁö ¾Ê°í, ½É¸®Àû °¥µîÀÌ ½ÉÇÒ °æ¿ì¿¡ ´õ¿í Áõ»óÀÌ ½ÉÇØÁö°í Áõ»óÀÇ ¹ßÇöÀ¸·Î ÀÎÇØ¼­ ³»ºÎÀû °¥µîÀÌ °¨¼ÒµÇ°í Áõ»óÀÇ ¹ßÇöÀ¸·Î ÀÎÇÑ 2Â÷Àû À̵æ(°¡Á·µéÀÇ °ü½ÉÁýÁß, µ¹ºÁÁÜ)ÀÌ Àִ °ÍÀÌ ÀÌ ÀüȯÀå¾ÖÀǠƯ¡ÀÌ´Ù. ´ë°³ ÀÌ ÀüȯÀå¾Ö È¯Àڴ ÀÚ½ÅÀÇ Áúȯ¿¡ ´ëÇØ¼­ Æ¯Â¡ÀûÀ¸·Î ¸Å¿ì ¹«°ü½ÉÇѠŵµ¸¦ ÃëÇÑ´Ù.
¿µ¹® affective disorder ÇÑ±Û Á¤µ¿Àå¾Ö
¼³¸í   
  ÁַΠ±âºÐÀÇ Àå¾Ö°¡ ÁÖÃàÀÌ µÇ´Â ÀÏ·ÃÀÇ Á¤½ÅÀå¾ÖÀÌ´Ù. ÀÌ º´ÀÇ ¹üÁÖ¿¡´Â(¿ì¿ïº´£­Áö¼ÓÀûÀ¸·Î ¿ì¿ïÇÑ ±âºÐÀÌ ¿ÜºÎÀڱذú °ü°è¾øÀÌ ³ªÅ¸³ª´Â º´), (Á¶º´£­Áö¼ÓÀûÀ¸·Î µé¶á ±âºÐÀÌ ¿ÜºÎÀڱذú °ü°è¾øÀÌ °è¼ÓµÇ´Â º´) µîÀÌ Æ÷ÇԵȴÙ.
¿µ¹® psychiatric disorder(s) ÇÑ±Û Á¤½ÅÁúȯ
¼³¸í   
  Á¤½Å»óÅ¿¡ ÀÌ»óÀÌ Àִ ÁúȯÀ¸·Î, Á¤½ÅºÐ¿­º´, Á¤µ¿Àå¾Ö, ÀΰÝÀå¾Ö µîÀÌ ÀÖ´Ù.
¿µ¹® learning disorder ÇÑ±Û ÇнÀÀå¾Ö
¼³¸í   
  Áö´ÉÀº Á¤»óÀÌÁö¸¸ µè±â, ¸»Çϱâ, Àбâ, ¾²±â, Ã߸® ¶Ç´Â °è»ê´É·Â¿¡ ½É°¢ÇÑ ¹®Á¦°¡ ³ªÅ¸³ª´Â ¿©·¯ Àå¾ÖµéÀ» ÀÏÄ´ ¿ë¾î. À̷ΠÀÎÇØ Çо÷¼ºÀû ¹× Àڽۨ ÀúÇÏ, ´ëÀΰü°è¿¡¼­µµ »ç±³ ´É·ÂÀÌ ¹Ì¼÷ÇÏ¿© ÀÏ»ó»ýȰÀÇ ¸ðµç ¸é¿¡¼­ ¹®Á¦°¡ ³ªÅ¸³­´Ù. ¼ºÀα⠻çȸÀûÀÀ·Â¿¡µµ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖÀ¸¸ç, ÇൿÀå¾Ö, ÁÖÀǷ°áÇÌ, °úÀ׿Àå¾Ö, ¿ì¿ïÀå¾Ö µî°ú µ¿¹ÝµÇ¾î ³ªÅ¸³¯ ¼ö ÀÖ´Ù. ±× À¯º´·üÀº ³·°Ô´Â 1.7%, ³ô°Ô´Â 30% Á¤µµ·Î ÃßÁ¤Çϰí ÀÖÁö¸¸ Çе¿±â ¾Æµ¿ÀÇ ¾à 3~9%°¡ ÀÌ Àå¾Ö¸¦ °®°í Àִ °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. ±âÃÊÇнÀ±â´É°Ë»ç¸¦ ÅëÇÏ¿© Áø´ÜÇÑ´Ù. ÇнÀÀÇ ±âȸ³ª ±³À°ÀûÀΠÀÚ±ØÀÌ ºÎÁ·ÇÑ °æ¿ì, ÁýÁ߷ ºÎÁ·, ¿ì¿ïÁõ-ºÒ¾È µî Á¤¼­Àû ¹®Á¦, ½Å°æÇÐÀû À̻󿡠ÀÇÇÑ °æ¿ì µîÀÌ ¿øÀÎÀÏ ¼ö ÀÖ´Ù. ÇнÀ°ú °ü·ÃÀÌ Àִ ³ú±â´É°ú ¿¬°üµÈ Æ¯Á¤¿µ¿ª¿¡ °áÇÔÀÌ Àְųª ¹ßÀ°Áö¿¬ ¶Ç´Â Àå¾Ö°¡ Àִ °æ¿ìµµ ¿øÀÎÀÌ µÈ´Ù. ¶ÇÇÑ ºÎ¸ð°¡ Á¶±â¿¡ ÀÚ³àÀÇ ´É·Â°ú Àû¼ºÀ» Àß ¾ËÁö ¸øÇϴ °æ¿ì¿¡µµ ¸¹ÀÌ »ý±ä´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • neonatal period
    ½Å»ý¾Æ±â
  • neonatal purpura
    ½Å»ý¾ÆÀÚ»ö¹Ý
  • neonatal screening
    ½Å»ý¾Æ¼±º°°Ë»ç
  • neonatal thrombocytopenia
    ½Å»ý¾ÆÇ÷¼ÒÆÇ°¨¼Ò(Áõ)
  • antisocial personality disorder
    ¹Ý»çȸÀûÀΰÝÀå¾Ö
  • anxiety disorder
    ºÒ¾ÈÀå¾Ö
  • anxious personality disorder
    ºÒ¾ÈÀΰÝÀå¾Ö
  • articulation disorder
    ¹ßÀ½Àå¾Ö
  • asocial personality disorder
    ºñ»çȸÀûÀΰÝÀå¾Ö
  • attention deficit disorder
    ÁÖÀǷ°áÇÌÀå¾Ö
  • attention deficit hyperactivity disorder
    ÁÖÀǷ°áÇ̰ú´ÙȰµ¿Àå¾Ö
  • auditory disorder
    û°¢Àå¾Ö, ³­Ã»
  • autistic disorder
    ÀÚÆóÀå¾Ö, ÀÚÆóº´
  • autoimmune disorder
    ÀÚ°¡¸é¿ªÁúȯ
  • autosomal dominant disorder
    º¸Åë¿°»öü¿ì¼ºÁúȯ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • oppositional defiant disorder
    Àû´ëÀû¹ÝÇ×Àå¾Ö
  • panic disorder
    °øÈ²Àå¾Ö, °øÈ²º´
  • paranoid disorder
    (¢¡delusional disorder) ÆíÁýÀå¾Ö, ÆíÁýº´
  • personality disorder
    ÀΰÝÀå¾Ö, ¼º°ÝÀå¾Ö
  • phonation disorder
    ¹ß¼ºÀå¾Ö
  • platelet function disorder
    Ç÷¼ÒÆÇ±â´ÉÀÌ»ó
  • premenstrual dysphoric disorder
    ¿ù°æÀüºÒÄèÀå¾Ö, ¿ù°æÀüºÒÄ躴
  • psychogenic disorder
    Á¤½ÅÅ¿Àå¾Ö, ½ÉÀμºÀå¾Ö
  • reading disorder
    ÀбâÀå¾Ö
  • renal disorder
    ÄáÆÏÀå¾Ö, ½ÅÀåÀå¾Ö
  • schizophreniform disorder
    Á¤½ÅºÐ¿­ÇüÀå¾Ö, Á¤½ÅºÐ¿­Çüº´
  • seizure disorder
    ¹ßÀÛÀå¾Ö
  • sexual disorder
    ¼ºÀå¾Ö
  • somatic disorder
    ½ÅüÀå¾Ö
  • somatization disorder
    ½ÅüȭÀå¾Ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • neonatal thrombocytopenia
    ½Å»ý¾ÆÀúÇ÷¼ÒÆÇÁõ
  • neonatal thymectomy
    ½Å»ý¾Æ°¡½¿»ùÀýÁ¦(¼ú)
  • neonatal alloimmune thrombocytopenia
    ½Å»ý¾Æµ¿Á¾¸é¿ªÀúÇ÷¼ÒÆÇÁõ
  • neonatal death rate
    (¢¡neonatal mortality rate) ½Å»ý¾Æ»ç¸Á·ü
  • neonatal mortality rate
    ½Å»ý¾Æ»ç¸Á·ü
  • adhesion deficiency disorder
    À¯Âø°áÇÌÀå¾Ö
  • adjustment disorder
    ÀûÀÀÀå¾Ö
  • affective disorder
    Á¤µ¿Àå¾Ö, Á¤µ¿º´
  • amnestic disorder
    ±â¾ï»ó½ÇÀå¾Ö
  • anankastic personality disorder
    °­¹ÚÀΰÝÀå¾Ö
  • antisocial personality disorder
    ¹Ý»çȸÀΰÝÀå¾Ö
  • anxiety disorder
    ºÒ¾ÈÀå¾Ö
  • anxious personality disorder
    ºÒ¾ÈÀΰÝÀå¾Ö
  • articulation disorder
    ÀÔ¼Ò¸®Àå¾Ö, ¹ßÀ½Àå¾Ö
  • asocial personality disorder
    ºñ»çȸÀΰÝÀå¾Ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • hyperkinetic disorder
    °ú´Ù¿îµ¿¼º Àå¾Ö, °ú´Ù¿îµ¿º´
  • hypnotic-dependent disorder
    ¼ö¸éÁ¦ÀÇÁ¸Àå¾Ö, ~º´
  • hypoactive sexual desire disorder
    ¼º¿å°¨¼ÒÀå¾Ö, ~º´
  • hypothalamic disorder
    ½Ã»óÇϺÎÁúȯ.
  • identity disorder
    ÁÖü¼º Àå¾Ö
  • immune disorder
    ¸é¿ª Àå¾Ö
  • impulse control disorder
    Ãæµ¿ Á¶ÀýÀå¾Ö, ~º´
  • impulse disorder
    Ãæµ¿ Àå¾Ö, Ãæµ¿º´
  • impulse disorder, hyperkinetic
    °úÀ׿¼º Ãæµ¿Àå¾Ö
  • impulse disorder, hyperkinetic
    °ú¿îµ¿¼º Ãæµ¿Àå¾Ö.
  • impulse-control disorder
    Ãæµ¿Á¶ÀýÀå¾Ö
  • induced delusional disorder
    À¯¹ß¼º ¸Á»óÀå¾Ö, ~¸Á»óº´
  • persistent somatoform pain disorder
    Áö¼Ó¼º ½ÅüÇü µ¿ÅëÀå¾Ö(º´)
  • personality disorder
    ÀΰÝÀå¾Ö(¡­î¡äô).
  • personality disorder, amoral
    ºñµµ´öÀû ÀΰÝÀå¾Ö
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • medullary endocrine cell
    ¼ÓÁú³»ºÐºñ¼¼Æ÷
  • multiple endocrine adenoma
    ´Ù¹ß¼º ³»ºÐºñ¼±Á¾(¡­Ò®ÝÂù²àÍðþ).
  • multiple endocrine adenoma
    ´Ù¹ß¼º ³»ºÐºñ¼±Á¾(¡­Ò®ÝÂù²àÍðþ)
  • multiple endocrine adenoma
    ´Ù¹ß¼º ³»ºÐºñ¼±Á¾(¡­³»ºÐÇʼ±Á¾).
  • multiple endocrine adenomatosis =MEA
    ´Ù¹ß¼º ³»ºÐºñ¼±Á¾Áõ(ÒýÛ¡àõÒ®ÝÂù²àÍðþñø).
  • multiple endocrine adenomatosis =MEA
    ´Ù¹ß¼º ³»ºÐºñ¼±Á¾Áõ(´Ù¹ß¼º³»ºÐÇʼ±Á¾Áõ).
  • multiple endocrine adenomatosis =mea
    ´Ù¹ß¼º ³»ºÐºñ¼±Á¾Áõ(¡­ñø)
  • multiple endocrine neoplasia
    ´Ù¹ß¼º ³»ºÐºñ ½Å»ý¹°
  • multiple endocrine neoplasia
    º¹ÇÕ³»ºÐºñ¼±½Å»ý¹°(ãæßæÚª)
  • multiple endocrine neoplasia syndrome
    ´Ù¹ß¼º ³»ºÐºñ¼±Á¾Áõ
  • multiple endocrine neoplasia(MEN)
  • pancreatic endocrine cell
    ÀÌÀÚ³»ºÐºñ¼¼Æ÷
  • alloimmune neonatal thrombocytopenia=ANN
    µ¿Á¾¸é¿ª¼º½Å»ý¾ÆÇ÷¼ÒÆÇ°¨¼ÒÁõ
  • early neonatal mortality rate
    ½Å»ý¾Æ»ç¸Á·ü(ËàË×ËâË×ËÎËô).
  • early neonatal mortality rate
    ½Å»ý¾Æ»ç¸Á·ü(ãæßæä®ÞÝØÌëÒ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
AES acetone-extracted serum; American Electroencephalographic Society; American Encephalographic Society...
EC effective concentration; ejection click; electrochemical; electron capture; embryonal carcinoma; eme...
E&M endocrine and metabolic
Endo endocardial, endocardium; endocrine, endocrinology; endodontics; endotracheal
FMEN familial multiple endocrine neoplasia
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
MEN2a Multiple Endocrine Neoplasia Type 2a
MEN-I Multiple Endocrine Neoplasia Type I
MEN 2B Multiple Endocrine Neoplasia type 2B
MEN2 Multiple endocrine neoplasia Type 2
PET Pancreatic endocrine tumors
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acute brain disorder
    ±Þ¼º ³úÀå¾Ö
  • adjustment disorder
    ÀûÀÀÀå¾Ö, ÀûÀÀÀå¾Ö º´
  • adjustment sleep disorder
    ÀûÀÀ¼º ¼ö¸éÀå¾Ö, ÀûÀÀ¼º ¼ö¸éÀå¾Ö º´, ¼ö¸é Á¶Á¤ Àå¾Ö, ¼ö¸é Á¶Á¤ Àå¾Ö º´
  • affective disorder
    Á¤µ¿Àå¾Ö
  • antisocial personality disorder
    ¹Ý»çȸÀû ÀÎ°Ý Àå¾Ö
  • anxiety disorder
    ºÒ¾È Àå¾Ö
    °­¹ÚÁõ, ¿Ü»ó ÈÄ ½ºÆ®·¹½ºÀå¾Ö, °øÆ÷Áõ, °øÈ²Àå¾Ö¸¦ Æ÷ÇÔÇÏ´Â ³ÐÀº ÀǹÌÀÇ ½É¸®Àû Áúº´À¸·Î¼­ ºÒ¾È¿¡ ´ëÇÑ ºñÇö½ÇÀûÀ̰í Áö¼ÓÀûÀÎ ´À³¦, ºÒÈ®½Ç¼º, ¹Ì·¡ÀÇ ¿ì·Á³ª À§Çè¿¡ ´ëÇÑ µÎ·Á¿òÀÌ Æ¯Â¡À̸ç, ±äÀå°¨À̳ª ºÒ¾ÈÀ» µ¿¹ÝÇÑ´Ù. À̰ÍÀº ÀûÀÀ ±â´ÉÀÌ Á¦ÇѵǸç, ȯÀÚ¸¦ ¾È½É½Ã۸é Áõ»óÀÌ ¿ÏÈ­µÈ´Ù.
  • articular disorder
    °üÀý Àå¾Ö
  • atypical factitious disorder
    ºñÁ¤Çü °¡À强 Àå¾Ö
  • autoimmune disorder
    ÀÚ°¡ ¸é¿ª Àå¾Ö
    ½Åü°¡ ÀÚ±â Àڽſ¡ ´ëÇØ Àå¾Ö°¡ ÀÖ´Â ¸é¿ª ¹ÝÀÀÀ» ÀÏÀ¸ÄÑ ·ù¸¶Æ¼¼º °üÀý¿°, ÇǺΠ°æÈ­Áõ°ú °°ÀÌ ÀÚ½ÅÀÇ Á¶Á÷ ÆÄ±«¸¦ À¯¹ßÇÏ´Â Áúȯ.
  • autosomal dominant disorder
    »ó¿°»öü ¿ì¼º À¯Àü Áúȯ
  • autosomal recessive disorder
    »ó¿°»öü ¿­¼º Áúȯ
  • behavior disorder
    Çൿ Áúȯ
    Á¤½Å ÁúȯÀ» °¡¸®Å°´Âµ¥ »ç¿ëµÇ´Â ÃÑĪ. ƯÈ÷ ÁöÀû, °¨Á¤Àû, ÇൿÀû °¢ Ãø¸éÀÇ Á¤½Å Àå¾Ö·Î, ±âÁúÀû ÀÎÀÚ¿Í »ó°üÀÌ ¾ø´Â °Í.
  • behavioral disorder
    Çൿ Àå¾Ö
  • blood disorder
    Ç÷¾× Áúȯ
  • carbohydrate metabolism disorder
    ź¼öÈ­¹° ´ë»ç Àå¾Ö
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
Brazelton's Neonatal Behavioural Assessment Scale A scale used by obstetricians, paediatricians, and paediatric psychologists to assess the sensory, motor, emotional and physical development of the neonate, usually beginning at birth or in the first month of life.
(05 Mar 2000)
rate, neonatal mortality The number of children dying under 28 days of age divided by the number of live births that year. The neonatal mortality rate in the united states, which was 8.4 per 1,000 live births in 1980, declined to 5.8 per 1,000 live births in 1990.
(12 Dec 1998)
mortality rate, neonatal The number of children dying under 28 days of age divided by the number of live births that year. The neonatal mortality rate in the united states, which was 8.4 per 1,000 live births in 1980, declined to 5.8 per 1,000 live births in 1990.
(12 Dec 1998)
neonatal <paediatrics> Pertaining to the first four weeks after birth.
Origin: L. Natus = born
(18 Nov 1997)
neonatal abstinence syndrome <syndrome> Foetal and neonatal addiction and withdrawal as a result of the mother's dependence on drugs during pregnancy. Withdrawal or abstinence symptoms develop shortly after birth. Symptoms exhibited are loud, high-pitched crying, sweating, yawning and gastrointestinal disturbances.
(12 Dec 1998)
neonatal anaemia <haematology> A condition which develops in the foetus due to an incompatibility between the mother's blood type (RH factor) and the baby's. Maternal antibodies, which enter the foetal circulation during delivery attack the baby's red blood cells leading to haemolysis (rupture of the cells).
Symptoms include an infant with an enlarged liver and spleen, swelling, jaundice and anaemia.
(27 Sep 1997)
neonatal apoplexy Intracranial haemorrhage in newborn children.
(05 Mar 2000)
neonatal arthritis of foals Bacterial polyarthritis caused by umbilical infections by several bacterial species.
(05 Mar 2000)
neonatal calf diarrhoea virus One of two virus's causing neonatal calf diarrhoea; a reovirus-like virus is associated with disease in newborn calves, and a coronavirus is associated with disease in calves over 5 days of age.
(05 Mar 2000)
neonatal conjunctivitis Acute conjunctival inflammation in the newborn, usually caused by maternal gonococcal infection. The causative agent is neisseria gonorrhoeae. The baby's eyes are contaminated during passage through the birth canal.
(12 Dec 1998)
neonatal death Death of a young, liveborn infant; classified as:
(05 Mar 2000)
neonatal diagnosis Systematic evaluation of the newborn for evidence of disease or malformations, and the conclusion reached.
(05 Mar 2000)
neonatal diseases and abnormalities Diseases existing at birth and often before birth, regardless of causation. Of these congenital diseases, those characterised by structural deformities are termed abnormalities.
(12 Dec 1998)
neonatal heart failure <radiology> most likely cause, premature: patent ductus arteriosus, full term: hypoplastic left heart, 2nd week: coarctation and VSD aetiology, valvular stenosis, mitral stenosis, aortic stenosis, aortic coarctation, vein of Galen aneurysm, infantile haemangioendothelioma of liver, hypoplastic left heart see also: congestive heart failure in kids
(12 Dec 1998)
neonatal hepatitis Hepatitis in the neonatal period presumed to be due to a variety of causes, chiefly viral; characterised by direct and indirect bilirubinaemia, hepatocellular degeneration, and appearance of multinucleated giant cells; may be difficult to distinguish from biliary atresia, but is more likely to end with recovery, although cirrhosis may develop.
Synonym: giant cell hepatitis.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á